Table 2.
Baseline risk assessment characteristics of 200 patients attending their GPa
| Non-Aboriginal (n = 134) |
Aboriginal (n = 66) |
Total (n = 200) |
|
| Age in years (mean ± SD) | 51.5 ± 29.8 | 50.1 ± 10.62 | 51.1 ± 25.1 |
| Female | 79 (59%) | 45 (68%) | 124 (62%) |
| Recorded diabetes | 37 (28%) | 30 (46%) | 68 (34%) |
| Current smokerb | 36 (27%) | 33 (50%) | 69 (35%) |
| 5-year adjusted CVD risk | |||
| Low risk (< 10%) | 28 (21%) | 16 (24%) | 44 (22%) |
| Moderate risk (10-15%) | 12 (9%) | 9 (14%) | 21 (11%) |
| High risk (> 15%), excluding established CVD |
28 (21%) | 11 (17%) | 39 (20%) |
| Established CVD | 30 (22%) | 13 (20%) | 43 (22%) |
| Unable to estimate risk due to missing information |
36 (27%) | 17 (26%) | 53 (27%) |
| Medication prescribed | |||
| Lipid-lowering | 67 (50%) | 31 (47%) | 98 (49%) |
| Anti-platelet | 50 (37%) | 20 (30%) | 70 (35%) |
| BP-lowering | 85 (63%) | 37 (56%) | 122 (61%) |
a Reported as no. (%) unless otherwise indicated. Percentages may not add to 100% due to rounding.
b Current smoker or quit within past 12 months.